NewAmsterdam Pharma

NewAmsterdam Pharma NewAmsterdam Pharma Corporation is a late-stage clinical biopharma company. Intended for US audiences Intended for US audiences only.

NewAmsterdam Pharma Corporation is a late-stage clinical biopharma company developing therapies for cardiometabolic diseases.

Everything we do starts with our people.Together, we’re working to improve outcomes for people with cardiovascular disea...
08/25/2026

Everything we do starts with our people.

Together, we’re working to improve outcomes for people with cardiovascular disease and other lipid-related conditions.

The best is yet to come, and our team is hiring. Explore our open roles: https://www.newamsterdampharma.com/careers/

08/11/2026

Behind each statistic are real patients and families that feel the impact of untreated cardiovascular disease (CVD). At NewAmsterdam, their stories and experiences drive us to continue researching and developing additional approaches to lipid management.

Learn more about how we are working to change the landscape of lipid-lowering treatment: https://www.newamsterdampharma.com/our-focus/

Even with existing treatment options, many patients remain unable to reach LDL‑C goals and continue to face cardiovascul...
08/06/2026

Even with existing treatment options, many patients remain unable to reach LDL‑C goals and continue to face cardiovascular health risks. Addressing this challenge requires continued innovation in cardiovascular care and the development of new therapies.

At NewAmsterdam, we’re determined to change that. Learn more about our work: https://www.newamsterdampharma.com/unmet-need-cardiovascular-disease/

07/30/2026

When Dr. Michael Davidson says, “expect more,” he’s challenging us to push beyond today’s limitations. Rather than settling for the status quo, we are working to change the landscape of treatment for those who remain at risk.

Learn more about our mission: https://www.newamsterdampharma.com/about-us/

07/21/2026

Science is moving fast, especially at the intersection of cardiovascular disease and neurology.

Recently, the Alzheimer's Association published its annual 2026 Facts & Figures report, which adds to the growing body of evidence showing midlife high cholesterol is a risk factor for dementia – research that underscores the importance of understanding the link between these factors.

For patients, this connection points to what’s at stake and why advancing our understanding of heart and brain health matters.

Learn more about our research: https://www.newamsterdampharma.com/lipid-related-conditions/

06/18/2026

Compared to women, men have a greater risk of heart attack and experience heart attacks earlier in life.

During , that’s an important reminder that prevention matters. Understanding cardiovascular risk factors, including LDL cholesterol, HDL cholesterol, and Lp(a), can play an important role in supporting long-term heart health.

Learn more: https://www.expectmoreforldl.com/ldl-c-goals-guidelines-and-treatment/

As we expand our clinical development efforts in Alzheimer’s disease, we’re looking for an experienced physician leader ...
05/13/2026

As we expand our clinical development efforts in Alzheimer’s disease, we’re looking for an experienced physician leader to help shape trial design, monitoring, data analysis, and interpretation across this important program.

Learn more about the Executive Medical Director, Alzheimer’s Disease, opportunity at NewAmsterdam Pharma and how you can help advance innovative science for patients.

https://newamsterdampharma.wd108.myworkdayjobs.com/New_Amsterdam_External_Career_Site

05/10/2026

Lipid-related markers play an important role in understanding cardiovascular risk.

In recognition of , we’re highlighting the importance of advancing lipid science to help improve how cardiovascular risk is identified and addressed.

Explore how LDL-C, Lp(a), and HDL-C fit into cardiovascular risk:
https://www.expectmoreforldl.com/ldl-c-goals-guidelines-and-treatment/

May is , and it’s an important reminder that cardiovascular disease remains the leading cause of death in women. Women ...
05/08/2026

May is , and it’s an important reminder that cardiovascular disease remains the leading cause of death in women. Women represent nearly half of all adults living with cardiovascular disease, and trends suggest the burden could grow without greater awareness, prevention, and support.

More attention to women’s heart health can help drive earlier conversations, better care, and improved outcomes.

Learn more: https://www.ahajournals.org/doi/10.1161/CIR.0000000000001406

04/22/2026

On , we’re recognizing the colleagues who keep our teams running smoothly every day. Thank you for your organization, dedication, and steady support—your work makes a meaningful difference across the company and helps keep our focus where it belongs: on delivering for patients.

Address

Aventura, FL

Website

Alerts

Be the first to know and let us send you an email when NewAmsterdam Pharma posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Category